Oruka Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $2.6M | $20.6M | $6.2M |
| Jun 2017 | $2.5M | $17.3M | $9.1M |
| Sep 2017 | $2.6M | $16.9M | $8.1M |
| Dec 2017 | $2.1M | $12.4M | $8.7M |
| Mar 2018 | $1.7M | $12.8M | $12.1M |
| Jun 2018 | $1.1M | $10.1M | $9.6M |
| Sep 2018 | $982.0K | $8.4M | $8.1M |
| Dec 2018 | $793.0K | $6.8M | $6.6M |
| Mar 2019 | $1.3M | $8.6M | $8.0M |
| Jun 2019 | $1.2M | $10.4M | $10.0M |
| Sep 2019 | $1.2M | $9.9M | $9.6M |
| Dec 2019 | $926.0K | $8.5M | $8.4M |
| Mar 2020 | $1.2M | $7.5M | $6.7M |
| Jun 2020 | $1.3M | $11.6M | $11.0M |
| Sep 2020 | $1.5M | $52.0M | $51.1M |
| Dec 2020 | $3.9M | $50.4M | $49.1M |
| Mar 2021 | $3.3M | $69.2M | $66.9M |
| Jun 2021 | $4.1M | $65.3M | $63.2M |
| Sep 2021 | $3.6M | $60.2M | $58.3M |
| Dec 2021 | $3.9M | $54.9M | $53.4M |
| Mar 2022 | $3.1M | $51.0M | $49.1M |
| Jun 2022 | $3.1M | $48.1M | $46.4M |
| Sep 2022 | $2.2M | $45.0M | $43.9M |
| Dec 2022 | $1.4M | $43.1M | $42.4M |
| Mar 2023 | $1.5M | $42.1M | $40.9M |
| Jun 2023 | $1.8M | $41.1M | $40.2M |
| Sep 2023 | $1.2M | $39.2M | $38.5M |
| Dec 2023 | $841.0K | $37.9M | $37.4M |
| Feb 2024 | $0 | $1.0K | — |
| Mar 2024 | $1.6M | $36.7M | $35.9M |
| Jun 2024 | $1.3M | $33.8M | $33.3M |
| Sep 2024 | $18.9M | $414.1M | $410.9M |
| Dec 2024 | $13.8M | $396.0M | $61.6M |
| Mar 2025 | $12.4M | $377.1M | $83.6M |
| Jun 2025 | $13.8M | $357.4M | $65.4M |
| Sep 2025 | $22.5M | $509.3M | $91.3M |
| Dec 2025 | $16.7M | $488.6M | $46.9M |
| Mar 2026 | $17.8M | $504.5M | $49.5M |
| Jun 2026 | $24.8M | $1.14B | $268.5M |